Developer docs
API playgroundTry for free, no card

Search company profiles

CapsoVision

Full company profile

uuid00006qy

Namestring
CapsoVision
Legal namestring
CapsoVision, Inc.
Websiteurl
capsovision.com
Company typeenum
Public
Founded yearint
2005
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSaratoga, United States
HQ citystring
Saratoga
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
capsule endoscopy systems, small bowel imaging, medical capsule devices, cloud endoscopy software, AI-assisted diagnostics
Industry1 code
PRIMARYHLAHADAB
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Capsule Endoscopy Systems
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1CapsoCam Plus Capsule Sales
TypeHardware Sales
Description

Sale of single-use CapsoCam Plus capsules to healthcare providers (gastroenterologists in clinics and hospitals). The capsule is the primary consumable/product revenue driver.

investors.capsovision.com
2Software/SaaS (CapsoCloud)
TypeSubscription Recurring
Description

Cloud-based software platform for capsule endoscopy data management, streaming, and review. Provided as part of the system offering to healthcare providers.

capsovision.com
3Third-Party Reading Services
TypeProfessional Services
Description

Third-party report reading services by U.S.-based board-certified gastroenterologists available for capsule endoscopy interpretation.

capsovision.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1CapsoCam Plus
Description

Wire-free capsule endoscopy system with 360-degree panoramic imaging for small bowel visualization. FDA-cleared for adults and pediatric patients aged 2 and above, and for remote ingestion.

capsovision.com
+5 more records
Core offering1 text field

CapsoVision designs, manufactures, and sells the CapsoCam Plus wire-free capsule endoscopy system, a single-use ingestible capsule with four laterally oriented onboard cameras that capture a 360-degree panoramic view of the small bowel mucosa. The capsule is paired with proprietary software: CapsoView for local video review, CapsoCloud for cloud-based clinical data management, and CapsoAccess for capsule data retrieval, and is sold to gastroenterologists in clinics and hospitals in the United States and through exclusive distributors internationally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 27% more lesion detection compared to PillCam
+5 more records
Product overview1 text field

CapsoVision offers a capsule endoscopy platform centered on the CapsoCam Plus system, a wire-free capsule with 360° panoramic imaging for small bowel visualization. The platform includes supporting software: CapsoView for local video review, CapsoCloud for cloud-based clinical data management, and CapsoAccess for capsule data retrieval. The company is expanding with AI-assisted workflow features (AI Highlights) and pipeline products targeting colon imaging (CapsoCam Colon) and pancreatic cancer screening (CapsoCam UGI).

Product and service5 records
1CapsoCam Plus
CategoryCapsule endoscopy hardware
Description

Wire-free, single-use capsule endoscopy system with four laterally oriented onboard cameras that capture a 360-degree panoramic view of the small bowel mucosa for gastroenterologists in clinics and hospitals, FDA-cleared for adult and pediatric (age 2+) use and for remote ingestion.

2CapsoView
CategoryEndoscopy review software
Description

Local diagnostic review software that provides a user-friendly interface for viewing CapsoCam Plus images, with multiple playback options and report generation capabilities, available on Mac and PC for gastroenterology clinicians.

3CapsoCloud
CategoryCloud-based clinical data management software
Description

Cloud-based clinical data management platform that enables healthcare providers to access capsule endoscopy exam data anytime via a HIPAA-compliant portal, supporting remote physician review and case management.

4CapsoAccess
CategoryCapsule data retrieval hardware/software
Description

Data access system that allows clinicians to extract in vivo images from the CapsoCam Plus capsule by placing the capsule into the system and initiating download, for use by gastroenterology practices performing capsule endoscopy.

5AI Highlights
CategoryAI-assisted endoscopy software
Description

AI-assisted review feature that analyzes frames captured by the CapsoCam Plus capsule during video processing to flag suspected clinically relevant findings, supporting physician review efficiency for small bowel capsule endoscopy studies.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-09
Description

Development agreement for CMOS image sensors for CapsoVision's capsule endoscopy products. The amended agreement increased total development fee from approximately $4.1 million to $5.1 million due to additional features in the specification. Canon is developing custom CMOS image sensor samples for evaluation, clinical testing, and FDA 510(k) clearance for capsule endoscopies with advanced imaging technology including higher frame rates, resolution, and dynamic range.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Medtronic owns the PillCam capsule endoscopy franchise via its acquisition of Given Imaging. It is CapsoVision's principal direct competitor in small-bowel capsule endoscopy, offering end-facing capsule cameras with global distribution and an entrenched clinical evidence base.

TypeDirect peer
Description

Olympus is a leading GI endoscopy incumbent that markets capsule endoscopy products (e.g., Endocapsule) alongside its broader scope and processor portfolio. It competes head-to-head with CapsoCam Plus in capsule endoscopy and adjacent GI imaging procedures.

TypeDirect peer
Description

South Korean medical device company and developer of the MiroCam capsule endoscopy system. It is a direct capsule endoscopy competitor with comparable indications to CapsoCam Plus and meaningful APAC distribution.

TypeDirect peer
Description

Developer of the NavCam magnetically guided capsule endoscopy platform. AnX Robotica is a direct competitor targeting the same gastroenterology customer base with an alternative capsule-based diagnostic approach.

TypeDirect peer
Description

China-based manufacturer of OMOM capsule endoscopy systems. Competes directly with CapsoCam Plus in small-bowel capsule endoscopy, particularly across Asian markets where CapsoVision lacks direct distribution.

TypeBroad incumbent
Description

Fujifilm is a broad incumbent in endoscopy and GI imaging with a substantial installed base of scopes, processors, and imaging IT. While it has capsule endoscopy positioning, Fujifilm is a broader-portfolio competitor rather than a capsule specialist, similar to Olympus.

TypeEmerging player
Description

Developer of a non-invasive, ingestible X-ray-based capsule (C-Scan) for colorectal cancer screening. Check-Cap is an emerging player targeting colon imaging, intersecting directly with CapsoVision's CapsoCam Colon pipeline product.

TypeBroad incumbent
Description

Gastrointestinal endoscopy division of HOYA / Pentax, providing a broad portfolio of flexible endoscopes and GI imaging solutions. Competes in GI procedure rooms where capsule endoscopy is increasingly considered alongside flexible endoscopy.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds12 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CapsoVision

Capsule Endoscopy Systemscapsovision.com

CapsoVision firmographics

Firmographics
Name
CapsoVision
Legal name
CapsoVision, Inc.
Website
https://capsovision.com
Company type
Public
Founded year
2005
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

CapsoVision industry classification

Industry
Product category
Capsule Endoscopy Systems
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHADAB
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Capsule endoscopy systems
  • Small bowel imaging
  • Medical capsule devices
  • Cloud endoscopy software
  • AI-assisted diagnostics

Where CapsoVision is headquartered

Location

Headquarters

HQ city
Saratoga
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CapsoVision business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. CapsoCam Plus Capsule Sales: Sale of single-use CapsoCam Plus capsules to healthcare providers (gastroenterologists in clinics and hospitals). The capsule is the primary consumable/product revenue driver.
  2. Software/SaaS (CapsoCloud): Cloud-based software platform for capsule endoscopy data management, streaming, and review. Provided as part of the system offering to healthcare providers.
  3. Third-Party Reading Services: Third-party report reading services by U.S.-based board-certified gastroenterologists available for capsule endoscopy interpretation.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

CapsoVision product offering

Product offering

Core offering

CapsoVision designs, manufactures, and sells the CapsoCam Plus wire-free capsule endoscopy system, a single-use ingestible capsule with four laterally oriented onboard cameras that capture a 360-degree panoramic view of the small bowel mucosa. The capsule is paired with proprietary software: CapsoView for local video review, CapsoCloud for cloud-based clinical data management, and CapsoAccess for capsule data retrieval, and is sold to gastroenterologists in clinics and hospitals in the United States and through exclusive distributors internationally.

Product overview

CapsoVision offers a capsule endoscopy platform centered on the CapsoCam Plus system, a wire-free capsule with 360° panoramic imaging for small bowel visualization. The platform includes supporting software: CapsoView for local video review, CapsoCloud for cloud-based clinical data management, and CapsoAccess for capsule data retrieval. The company is expanding with AI-assisted workflow features (AI Highlights) and pipeline products targeting colon imaging (CapsoCam Colon) and pancreatic cancer screening (CapsoCam UGI).

Differentiator

Problem solved

Functional benefit

Brands

  • CapsoCam Plus: Wire-free capsule endoscopy system with 360-degree panoramic imaging for small bowel visualization. FDA-cleared for adults and pediatric patients aged 2 and above, and for remote ingestion.
  • CapsoCloud
  • CapsoView
  • CapsoAccess
  • AI Highlights
  • CapsoCam Colon

Products and services

  • CapsoCam Plus Wire-free, single-use capsule endoscopy system with four laterally oriented onboard cameras that capture a 360-degree panoramic view of the small bowel mucosa for gastroenterologists in clinics and hospitals, FDA-cleared for adult and pediatric (age 2+) use and for remote ingestion.
  • CapsoView Local diagnostic review software that provides a user-friendly interface for viewing CapsoCam Plus images, with multiple playback options and report generation capabilities, available on Mac and PC for gastroenterology clinicians.
  • CapsoCloud Cloud-based clinical data management platform that enables healthcare providers to access capsule endoscopy exam data anytime via a HIPAA-compliant portal, supporting remote physician review and case management.
  • CapsoAccess Data access system that allows clinicians to extract in vivo images from the CapsoCam Plus capsule by placing the capsule into the system and initiating download, for use by gastroenterology practices performing capsule endoscopy.
  • AI Highlights AI-assisted review feature that analyzes frames captured by the CapsoCam Plus capsule during video processing to flag suspected clinically relevant findings, supporting physician review efficiency for small bowel capsule endoscopy studies.

Quantifiable outcome

  • 27% more lesion detection compared to PillCam
  • +5 more outcomes

Companies that use CapsoVision

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles1 record

CapsoVision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

CapsoVision partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Canon Inc.coreStrategic or Co-development Partner · 9 March 2026Development agreement for CMOS image sensors for CapsoVision's capsule endoscopy products. The amended agreement increased total development fee from approximately $4.1 million to $5.1 million due to additional features in the specification. Canon is developing custom CMOS image sensor samples for evaluation, clinical testing, and FDA 510(k) clearance for capsule endoscopies with advanced imaging technology including higher frame rates, resolution, and dynamic range.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

CapsoVision competitors and assessment

Company assessment

Direct peers

  • Medtronic (Given Imaging PillCam): Medtronic owns the PillCam capsule endoscopy franchise via its acquisition of Given Imaging. It is CapsoVision's principal direct competitor in small-bowel capsule endoscopy, offering end-facing capsule cameras with global distribution and an entrenched clinical evidence base.
  • Olympus Corporation: Olympus is a leading GI endoscopy incumbent that markets capsule endoscopy products (e.g., Endocapsule) alongside its broader scope and processor portfolio. It competes head-to-head with CapsoCam Plus in capsule endoscopy and adjacent GI imaging procedures.
  • IntroMedic: South Korean medical device company and developer of the MiroCam capsule endoscopy system. It is a direct capsule endoscopy competitor with comparable indications to CapsoCam Plus and meaningful APAC distribution.
  • AnX Robotica: Developer of the NavCam magnetically guided capsule endoscopy platform. AnX Robotica is a direct competitor targeting the same gastroenterology customer base with an alternative capsule-based diagnostic approach.
  • Chongqing Jinshan Science & Technology (OMOM): China-based manufacturer of OMOM capsule endoscopy systems. Competes directly with CapsoCam Plus in small-bowel capsule endoscopy, particularly across Asian markets where CapsoVision lacks direct distribution.

Broad incumbents

  • Fujifilm Healthcare: Fujifilm is a broad incumbent in endoscopy and GI imaging with a substantial installed base of scopes, processors, and imaging IT. While it has capsule endoscopy positioning, Fujifilm is a broader-portfolio competitor rather than a capsule specialist, similar to Olympus.
  • Pentax Medical: Gastrointestinal endoscopy division of HOYA / Pentax, providing a broad portfolio of flexible endoscopes and GI imaging solutions. Competes in GI procedure rooms where capsule endoscopy is increasingly considered alongside flexible endoscopy.

Emerging players

  • Check-Cap: Developer of a non-invasive, ingestible X-ray-based capsule (C-Scan) for colorectal cancer screening. Check-Cap is an emerging player targeting colon imaging, intersecting directly with CapsoVision's CapsoCam Colon pipeline product.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

CapsoVision social profiles

Digital presence

CapsoVision compliance and trust

Trust signal

Compliance2 records

CapsoVision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CapsoVision leadership team

Management profile

Number of profiles

Profiles3 records

CapsoVision funding detail

Funding detail

Funding overview

Funding rounds12 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CapsoVision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CapsoVision

What does CapsoVision do?

CapsoVision designs, manufactures, and sells the CapsoCam Plus wire-free capsule endoscopy system, a single-use ingestible capsule with four laterally oriented onboard cameras that capture a 360-degree panoramic view of the small bowel mucosa. The capsule is paired with proprietary software: CapsoView for local video review, CapsoCloud for cloud-based clinical data management, and CapsoAccess for capsule data retrieval, and is sold to gastroenterologists in clinics and hospitals in the United States and through exclusive distributors internationally.

Is CapsoVision a public or private company?

CapsoVision is a public company. It is classified as public and is currently operating.

When was CapsoVision founded?

CapsoVision was founded in 2005. It employs 101 to 250 people.

Where is CapsoVision based?

CapsoVision is headquartered in Saratoga, United States, in the North America region.

How does CapsoVision make money?

Three revenue lines are on record. CapsoCam Plus Capsule Sales are the primary driver. The others are software/SaaS (CapsoCloud) and third-Party Reading Services.

Who are CapsoVision's main competitors?

Direct peers on record are Medtronic (Given Imaging PillCam), Olympus Corporation, IntroMedic, AnX Robotica and Chongqing Jinshan Science & Technology (OMOM). Broad incumbents are Fujifilm Healthcare and Pentax Medical. Check-Cap is listed as an emerging player.

Does CapsoVision have an API?

No public API is recorded for CapsoVision.

What industry is CapsoVision in?

CapsoVision's product category is Capsule Endoscopy Systems. Its primary akta.pro industry code is HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Seeking AlphaCapsoVision, Inc. GAAP EPS of -$0.15 misses by $0.01, revenue of $3.6M misses by $0.16MCapsoVision reported Q3 GAAP EPS of -$0.15, missing by $0.01, and revenue of $3.6M, missing by $0.16M. Cash and cash equivalents totaled $21.8 million as of September 30, 2026, and the company completed an $18 million registered direct offering during September.Business & FinancialCapsovision To Release Third Quarter 2026 Financial Results On November 12, 2026Capsovision will release its third-quarter 2026 financial results on November 12, 2026, with a conference call available via dial-in and webcast. The company's flagship product is CapsoCam Plus, a wire-free capsule endoscope, and its next pipeline product is CapsoCam Colon with enhanced AI.MarketBeatCapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer ScreeningCapsoVision outlined its strategy to expand capsule endoscopy into colon, pancreatic, and esophageal cancer screening, targeting five of the world's deadliest cancers. The company reported $3.6 million in Q2 revenue and plans to submit colon capsule data to the FDA in Q4. It also expects a pancreatic study to begin and an esophageal study in the second half of next year.Stock TitanCapsoVision to Present at 20th LD Micro Event Oct. 21CapsoVision executives will present at the 20th Annual LD Micro Main Event on October 21, 2026, in Los Angeles. The company, developing AI-enabled capsule endoscopy, will stream the presentation live and offer one-on-one meetings.Markets DailyComparing CapsoVision (NASDAQ:CV) & NeuroPace (NASDAQ:NPCE)NeuroPace outperforms CapsoVision on 12 of 15 factors, including higher revenue, lower P/E, and stronger analyst ratings. NeuroPace's consensus target price of $19.33 implies a 56% upside, versus CapsoVision's 43.5%. CapsoVision plans to launch CapsoCam Colon in the U.S. by mid-2026.Markets DailyAngioDynamics (NASDAQ:ANGO) & CapsoVision (NASDAQ:CV) Head to Head ComparisonCapsoVision and AngioDynamics are compared on earnings, valuation, and analyst ratings. AngioDynamics beats CapsoVision on 11 of 14 factors, with a higher consensus price target and upside. CapsoVision targets FDA clearance for its CapsoCam Colon capsule in 2026.American Banking and Market NewsBrainsway (NASDAQ:BWAY) and CapsoVision (NASDAQ:CV) Critical ReviewA comparison of CapsoVision and Brainsway evaluates their analyst ratings, valuation, and financials. Brainsway beats CapsoVision on 12 of 14 factors, but CapsoVision has higher potential upside at 50.01% versus 49.68%. CapsoVision targets FDA clearance for its CapsoCam Colon capsule by end of 2025.Investing.comStock Market News - Investing.com IndiaCapsoVision Inc. announced that its AI Highlights reading tool received FDA clearance on September 25. The tool, integrated with CapsoCam Plus, marks suspected abnormal lesions in small bowel capsule endoscopy studies. The clearance marks a milestone for the U.S. market, with international launch already underway.Defense WorldCritical Contrast: Zimmer Biomet (NYSE:ZBH) versus CapsoVision (NASDAQ:CV)Zimmer Biomet and CapsoVision are compared on profitability, risk, and analyst ratings. Zimmer Biomet has higher revenue and earnings, but CapsoVision shows higher potential upside. CapsoVision targets FDA clearance for its CapsoCam Colon capsule in 2026.AInvestCapsoVision's Downtrend Meets an FDA Countdown— Lose $5.00 and the Air Pocket OpensCapsoVision's stock trades at $5.97, below its 50-day and 200-day moving averages, with an August FDA decision on AI Highlights and a Q4 colon capsule submission as key catalysts. The company faces a $100 million share-sale overhang and $7.5 million quarterly losses, making the $5.00 IPO price a critical support level. A successful FDA clearance and recovery above $6.51 could revive investor confidence.